Is Cipro (ciprofloxacin) a fluoroquinolone antibiotic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Cipro a Fluoroquinolone?

Yes, Cipro (ciprofloxacin) is a fluoroquinolone antibiotic, specifically classified as a second-generation fluoroquinolone that was introduced in 1987. 1, 2

Classification and Development

Ciprofloxacin belongs to the fluoroquinolone class of antimicrobial agents, which evolved from the first quinolone antibacterial agent, nalidixic acid, introduced in the 1960s. The development timeline shows:

  • Nalidixic acid: First quinolone (1960s)
  • Fluorination of quinolone compounds led to:
    • Norfloxacin (1986)
    • Ciprofloxacin (1987)
    • Subsequent generations of fluoroquinolones 2

The FDA-approved drug label clearly identifies ciprofloxacin as a fluoroquinolone, stating: "Ciprofloxacin Tablets USP belongs to a class of antibiotics called fluoroquinolones." 1

Mechanism of Action

As a fluoroquinolone, ciprofloxacin exerts its bactericidal activity by:

  • Binding to DNA gyrase and topoisomerase IV
  • Impeding the formation of supercoiled DNA
  • Inhibiting the relaxation of supercoiled DNA
  • Promoting double-strand DNA breakage 2

This mechanism of action is characteristic of all fluoroquinolones, which primarily inhibit bacterial DNA gyrase. 3

Clinical Applications

Ciprofloxacin has been approved for various indications:

  • Complicated urinary tract infections and pyelonephritis
  • Postexposure treatment for inhalation anthrax
  • Certain serious infections in children when other alternatives are not appropriate 2

The American Academy of Pediatrics notes that ciprofloxacin is effective in eradicating nasal carriage of Neisseria meningitidis and can be used for infections caused by Pseudomonas aeruginosa when systemic therapy is required. 2

Common Characteristics with Other Fluoroquinolones

Like other fluoroquinolones, ciprofloxacin:

  • Has been associated with tendinopathy and tendon rupture
  • Can cause central nervous system effects
  • May lead to photosensitivity reactions
  • Can affect glucose homeostasis
  • May prolong QT interval 1, 2

These class effects are important considerations when prescribing any fluoroquinolone, including ciprofloxacin.

Conclusion

Based on the FDA drug label and multiple medical guidelines, Cipro (ciprofloxacin) is definitively classified as a fluoroquinolone antibiotic, specifically a second-generation fluoroquinolone that was introduced following the fluorination of quinolone compounds.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.